256 related articles for article (PubMed ID: 10648416)
1. A primitive hematopoietic cell is the target for the leukemic transformation in human philadelphia-positive acute lymphoblastic leukemia.
Cobaleda C; Gutiérrez-Cianca N; Pérez-Losada J; Flores T; García-Sanz R; González M; Sánchez-García I
Blood; 2000 Feb; 95(3):1007-13. PubMed ID: 10648416
[TBL] [Abstract][Full Text] [Related]
2. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell.
Bonnet D; Dick JE
Nat Med; 1997 Jul; 3(7):730-7. PubMed ID: 9212098
[TBL] [Abstract][Full Text] [Related]
3. BCR-ABL expression in different subpopulations of functionally characterized Ph+ CD34+ cells from patients with chronic myeloid leukemia.
Maguer-Satta V; Petzer AL; Eaves AC; Eaves CJ
Blood; 1996 Sep; 88(5):1796-804. PubMed ID: 8781437
[TBL] [Abstract][Full Text] [Related]
4. Philadelphia-positive B-cell acute lymphoblastic leukemia is initiated in an uncommitted progenitor cell.
Pérez-Losada J; Gutiérrez-Cianca N; Sánchez-García I
Leuk Lymphoma; 2001 Aug; 42(4):569-76. PubMed ID: 11697484
[TBL] [Abstract][Full Text] [Related]
5. Primitive quiescent leukemic cells from patients with chronic myeloid leukemia spontaneously initiate factor-independent growth in vitro in association with up-regulation of expression of interleukin-3.
Holyoake TL; Jiang X; Jorgensen HG; Graham S; Alcorn MJ; Laird C; Eaves AC; Eaves CJ
Blood; 2001 Feb; 97(3):720-8. PubMed ID: 11157490
[TBL] [Abstract][Full Text] [Related]
6. Distinct patterns of hematopoietic stem cell involvement in acute lymphoblastic leukemia.
Castor A; Nilsson L; Astrand-Grundström I; Buitenhuis M; Ramirez C; Anderson K; Strömbeck B; Garwicz S; Békássy AN; Schmiegelow K; Lausen B; Hokland P; Lehmann S; Juliusson G; Johansson B; Jacobsen SE
Nat Med; 2005 Jun; 11(6):630-7. PubMed ID: 15908956
[TBL] [Abstract][Full Text] [Related]
7. Involvement and functional impairment of the CD34(+)CD38(-)Thy-1(+) hematopoietic stem cell pool in myelodysplastic syndromes with trisomy 8.
Nilsson L; Astrand-Grundström I; Anderson K; Arvidsson I; Hokland P; Bryder D; Kjeldsen L; Johansson B; Hellström-Lindberg E; Hast R; Jacobsen SE
Blood; 2002 Jul; 100(1):259-67. PubMed ID: 12070035
[TBL] [Abstract][Full Text] [Related]
8. Hoechst 33342 efflux identifies a subpopulation of cytogenetically normal CD34(+)CD38(-) progenitor cells from patients with acute myeloid leukemia.
Feuring-Buske M; Hogge DE
Blood; 2001 Jun; 97(12):3882-9. PubMed ID: 11389030
[TBL] [Abstract][Full Text] [Related]
9. Dissociation between stem cell phenotype and NOD/SCID repopulating activity in human peripheral blood CD34(+) cells after ex vivo expansion.
Danet GH; Lee HW; Luongo JL; Simon MC; Bonnet DA
Exp Hematol; 2001 Dec; 29(12):1465-73. PubMed ID: 11750106
[TBL] [Abstract][Full Text] [Related]
10. Detection of leukemic cells in the CD34(+)CD38(-) bone marrow progenitor population in children with acute lymphoblastic leukemia.
George AA; Franklin J; Kerkof K; Shah AJ; Price M; Tsark E; Bockstoce D; Yao D; Hart N; Carcich S; Parkman R; Crooks GM; Weinberg K
Blood; 2001 Jun; 97(12):3925-30. PubMed ID: 11389036
[TBL] [Abstract][Full Text] [Related]
11. Identification of human juvenile chronic myelogenous leukemia stem cells capable of initiating the disease in primary and secondary SCID mice.
Lapidot T; Grunberger T; Vormoor J; Estrov Z; Kollet O; Bunin N; Zaizov R; Williams DE; Freedman MH
Blood; 1996 Oct; 88(7):2655-64. PubMed ID: 8839860
[TBL] [Abstract][Full Text] [Related]
12. Phenotype and function of human hematopoietic cells engrafting immune-deficient CB17-severe combined immunodeficiency mice and nonobese diabetic-severe combined immunodeficiency mice after transplantation of human cord blood mononuclear cells.
Pflumio F; Izac B; Katz A; Shultz LD; Vainchenker W; Coulombel L
Blood; 1996 Nov; 88(10):3731-40. PubMed ID: 8916937
[TBL] [Abstract][Full Text] [Related]
13. Rapid and efficient homing of human CD34(+)CD38(-/low)CXCR4(+) stem and progenitor cells to the bone marrow and spleen of NOD/SCID and NOD/SCID/B2m(null) mice.
Kollet O; Spiegel A; Peled A; Petit I; Byk T; Hershkoviz R; Guetta E; Barkai G; Nagler A; Lapidot T
Blood; 2001 May; 97(10):3283-91. PubMed ID: 11342460
[TBL] [Abstract][Full Text] [Related]
14. Transplantation of human umbilical cord blood cells in macrophage-depleted SCID mice: evidence for accessory cell involvement in expansion of immature CD34+CD38- cells.
Verstegen MM; van Hennik PB; Terpstra W; van den Bos C; Wielenga JJ; van Rooijen N; Ploemacher RE; Wagemaker G; Wognum AW
Blood; 1998 Mar; 91(6):1966-76. PubMed ID: 9490679
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic characterization of normal and CML CD34-positive cells: only the most primitive CML progenitors include Ph-neg cells.
De Fabritiis P; Dowding C; Bungey J; Chase A; Angus G; Szydlo R; Goldman JM
Leuk Lymphoma; 1993 Sep; 11(1-2):51-61. PubMed ID: 7693107
[TBL] [Abstract][Full Text] [Related]
16. Myeloid-lymphoid initiating cells (ML-IC) are highly enriched in the rhodamine-c-kit(+)CD33(-)CD38(-) fraction of umbilical cord CD34(+) cells.
Liu H; Verfaillie CM
Exp Hematol; 2002 Jun; 30(6):582-9. PubMed ID: 12063025
[TBL] [Abstract][Full Text] [Related]
17. Identification of human chronic myelogenous leukemia progenitor cells with hemangioblastic characteristics.
Fang B; Zheng C; Liao L; Han Q; Sun Z; Jiang X; Zhao RC
Blood; 2005 Apr; 105(7):2733-40. PubMed ID: 15591120
[TBL] [Abstract][Full Text] [Related]
18. Optimization of retroviral-mediated gene transfer to human NOD/SCID mouse repopulating cord blood cells through a systematic analysis of protocol variables.
Hennemann B; Conneally E; Pawliuk R; Leboulch P; Rose-John S; Reid D; Chuo JY; Humphries RK; Eaves CJ
Exp Hematol; 1999 May; 27(5):817-25. PubMed ID: 10340397
[TBL] [Abstract][Full Text] [Related]
19. Cytogenetically aberrant cells are present in the CD34+CD33-38-19- marrow compartment in children with acute lymphoblastic leukemia.
Quijano CA; Moore D; Arthur D; Feusner J; Winter SS; Pallavicini MG
Leukemia; 1997 Sep; 11(9):1508-15. PubMed ID: 9305606
[TBL] [Abstract][Full Text] [Related]
20. BCR/ABL-negative primitive progenitors suitable for transplantation can be selected from the marrow of most early-chronic phase but not accelerated-phase chronic myelogenous leukemia patients.
Verfaillie CM; Bhatia R; Miller W; Mortari F; Roy V; Burger S; McCullough J; Stieglbauer K; Dewald G; Heimfeld S; Miller JS; McGlave PB
Blood; 1996 Jun; 87(11):4770-9. PubMed ID: 8639848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
